FHAM
MDCO

Folger Hill Asset Management’s Medicines Co MDCO Stock Holding History

Folger Hill Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-400,000
Closed -$13.5M – 301
2016
Q2 		$13.5M Buy
+400,000
New +$14.1M 1.05% 23

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Folger Hill Asset Management's MDCO Position: Q1 2017 in Review

Folger Hill Asset Management sold out of Medicines Co (MDCO) in Q1 2017, closing a stake of 212,930 shares — an estimated $7.23M sold.

Folger Hill Asset Management first reported a position in MDCO in Q4 2015 and held it in 5 quarters. The position peaked at $26M in Q4 2015. 220 funds tracked by Wall St. Rank hold MDCO as of Q1 2017.

  • Folger Hill Asset Management reported no remaining Medicines Co position as of Q1 2017 after selling out during the quarter.
  • Folger Hill Asset Management sold 212,930 Medicines Co shares in Q1 2017, an estimated $7.23M.
  • Folger Hill Asset Management first reported a position in Medicines Co in Q4 2015 and held it in 5 quarters.
  • Folger Hill Asset Management's Medicines Co position peaked at $26M in Q4 2015.
  • 220 funds tracked by Wall St. Rank held Medicines Co as of Q1 2017.

Based on Folger Hill Asset Management's 13F filing for Q1 2017, filed 15 May 2017.